Primary Care ERectile Function Outcome Registry for Men

Exclusion Criteria

• •1. If at any other PDE-5 inhibitor (sildenafil, tadalafil, vardenafil, avanafil)
• •2. Concurrent use of organic nitrates (any form: glyceryl trinitrate, isosorbide mononitrate/dinitrate) - absolute contraindication
• •3. Recent or unstable cardiovascular disease
• •* Myocardial infarction or stroke in last 3 months
• •* Unstable angina
• •* Uncontrolled arrhythmia or heart failure NYHA III-IV
• •* Resting hypotension (SBP \< 90 mmHg) or uncontrolled hypertension (SBP \> 180 mmHg) per treating clinician
• •* Known severe hepatic impairment or severe renal impairment on dialysis (if local clinician deems unsafe)
• •* Known hypersensitivity to sildenafil or excipients
• •* Concomitant use of potent CYP3A4 inhibitors (e.g., ritonavir) - unless clinician documents safe plan/dose adjustment